[Form 4] The Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Michael Kirban, Executive Chairman and director of The Vita Coco Company, Inc. (COCO), reported insider transactions on Form 4. The filing shows a sale of 30,000 shares of common stock on 09/09/2025 effected pursuant to a Rule 10b5-1 trading plan at a weighted average price of $39.161 per share. The form also records a disposition of 127,629 shares and reports post-transaction beneficial ownership figures including 1,599,049 shares indirectly beneficially owned by Mr. Kirban and 615,681 shares held indirectly by the Michael Kirban Revocable Trust. The filing discloses multiple outstanding non-qualified stock options with exercise prices from $10.178 to $32.78 and vesting schedules through 2036, several of which are fully vested and currently exercisable.

Positive

• Sale executed under Rule 10b5-1 plan, indicating the transaction followed a pre-established trading program
• Detailed disclosure of option grants and vesting schedules, including several fully vested and exercisable tranches

Negative

• Insider dispositions reported: sale of 30,000 shares at a weighted average $39.161 and an additional disposition of 127,629 shares
• Significant outstanding options (totaling multiple tranches up to 546,000 shares) which could lead to future share issuance upon exercise

Insights

Securities/Equity Analyst

TL;DR: Insider completed a Rule 10b5-1 sale of 30,000 shares; significant option holdings remain outstanding.

The Form 4 documents a planned sale of 30,000 shares under a Rule 10b5-1 plan at a weighted average price of $39.161 and a separate reported disposition of 127,629 shares. Post-transaction beneficial ownership is disclosed as 1,599,049 shares indirect and 615,681 shares held by a revocable trust. The filing lists multiple non-qualified stock options with specified exercise prices and vesting timelines, including several fully vested and exercisable tranches. For investors, the combination of disclosed sales and remaining vested options is relevant for share supply considerations, while the Rule 10b5-1 designation indicates the sale followed a pre-established plan.

Corporate Governance Expert

TL;DR: Sale executed under a 10b5-1 plan; disclosure is thorough with option vesting detail.

The reporting provides explicit compliance signaling by noting the Rule 10b5-1 trading plan for the 30,000-share sale and includes detailed option schedules and vesting provisions. The form identifies indirect ownership through a revocable trust and shows that several stock options are fully vested and exercisable. These disclosures address transparency expectations for insider transactions and executive compensation instruments, allowing stakeholders to assess potential future insider-driven share issuance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kirban Michael

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2025		S(1)		30,000	D	$39.161(2)	1,599,049	I	by M. Kirban 2010
Common Stock								127,629	D
Common Stock								615,681	I	by M. Kirban Revoc(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(4)	12/16/2029	Common Stock	546,000		546,000	D
Non-Qualified Stock Option (right to buy)	$10.178							(5)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (right to buy)	$15							(6)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (right to buy)	$16.91							(7)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (right to buy)	$26.18							(8)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (right to buy)	$32.78							(9)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. These shares are held by the Michael Kirban Revocable Trust.

4. The stock option is fully vested and currently exercisable.

5. The stock option is fully vested and currently exercisable.

6. The stock option vests in four equal annual installments beginning on November 27, 2022.

7. The stock option vests in four equal annual installments beginning on March 10, 2024.

8. The stock option vests in four equal annual installments beginning on March 4, 2025.

9. The Stock Option vests in four equal annual installments beginning in March 3, 2026.

	By: Alison Klein, Attorney-in-Fact For: Michael Kirban	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Michael Kirban report on the Form 4 for COCO?

The Form 4 reports a sale of 30,000 shares on 09/09/2025 under a Rule 10b5-1 plan at a weighted average price of $39.161, a separate disposition of 127,629 shares, and post-transaction beneficial ownership totals of 1,599,049 and 615,681 shares held indirectly.

Was the 30,000-share sale by Michael Kirban part of a pre-arranged plan?

Yes. The filing explicitly states the sales were effected pursuant to a Rule 10b5-1 trading plan.

Does Michael Kirban hold exercisable options disclosed on the Form 4?

Yes. The filing lists multiple non-qualified stock options with exercise prices from $10.178 to $32.78; several options are noted as fully vested and currently exercisable.

How many shares does the Michael Kirban Revocable Trust hold according to the filing?

The Form 4 reports 615,681 shares held indirectly by the Michael Kirban Revocable Trust.

Who signed the Form 4 on behalf of Michael Kirban?

The form was signed by Alison Klein, Attorney-in-Fact for Michael Kirban on 09/11/2025.